Compare Corsair Gaming Inc (CRSR) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Corsair Gaming Inc vs IDEXX Laboratories, Inc. — how do they compare? Corsair Gaming Inc trades at $13.63 (market cap $1.42B), while IDEXX Laboratories, Inc. trades at $518 (market cap $40.43B). The key difference: IDEXX Laboratories, Inc. is far larger — about 28.5× Corsair Gaming Inc's market cap, and Corsair Gaming Inc is trading nearer its 52-week high, IDEXX Laboratories, Inc. nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Corsair Gaming Inc for 25 Days and IDEXX Laboratories, Inc. for 46 Days on average.
| CRSR | IDXX | |
|---|---|---|
Market Cap | $1.42B | $40.43B |
Volume | 1,160,938 | 692,164 |
Sector | Technology | Health |
52-Week High | $14.35 | $766.68 |
52-Week Low | $4.58 | $504.70 |
Typical Hold Time | 25 Days | 46 Days |
Enterprise Value | $1.41B | $41.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CRSR trades at $13.09, down 3.68% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company reported Q2 2026 EPS of $0.23, beating estimates of $0.07, and raised full-year guidance. Revenue for 2025 was $1.47B, with a net income margin of 2.53% in 2026 projections. Analyst consensus is a $12.40 price target with a mix of Buy (36%) and Hold (64%) ratings. Recent news includes product launches like the VOXARA microphone and strategic acquisitions.
Outlook is cautiously optimistic due to strong earnings performance and new product initiatives, but risks include competitive pressures in gaming hardware and volatile cash flow trends. The stock's valuation at a P/E of 42.23 may limit near-term upside unless profit growth accelerates. Institutional interest is positive, with Canada Pension Plan adding a position in Q3 2026.
IDEXX Laboratories (IDXX) trades at $513.14, up 1.28% with strong fundamentals including 25.03% net income margin and 74.21% ROE. The stock shows bearish technical signals but maintains consistent earnings beats and analyst consensus of $665 price target. Recent acquisition of CoVetAI expands AI capabilities in veterinary workflow intelligence, supporting long-term growth framework.
Outlook remains positive with revenue growth accelerating to $4.3B in 2025 and projected $4.6B in 2026. Key risks include foreign exchange headwinds and weaker U.S. veterinary visits. The 56.5% buy rating from analysts suggests continued confidence in the company's diagnostic innovation pipeline and recurring revenue economics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Corsair Gaming Inc
Corsair Gaming Inc is engaged in the business of providing high-performance gear for gamers and content creators. The product portfolio includes Cases, Keyboards, Mice, Headsets, Power Supplies, Gaming Computers, Gaming Chairs, Mousepads, and other related products. The company operates in two segments namely, Gamer and Creator peripherals, which is the key revenue generating segment
Read more on CRSR →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
